Children with attention-deficit disorders, who are allowed to jump queues at public places like theme parks may not benefit them
Children with attention-deficit disorders, who are allowed to jump queues at public places like theme parks may not benefit them, says a new study by Professor Katya Rubia, of London's Institute of Psychiatry.
Dr Rubia felt children with ADHD needed to learn the importance of waiting and by providing passes to jump queues, the society was not helping them at all.
Attention Deficit Hyperactivity Disorder-Causes-Symptoms-Diagnosis-Treatment-FAQ
Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disorder that affects normal behavior and impairs the ability to concentrate.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disorder that affects normal behavior and impairs the ability to concentrate.
It is estimated that some 360,000 children suffer from some degree of attention deficit hyperactivity disorder (ADHD) in the country.
Source-Medindia
RAS
Exposure to Smoking in Prenatal Stage Increases ADHD Risk in Children
Some expectant mothers who smoke during pregnancy may be exposing their baby to the risk of the attention deficit/hyperactivity disorder (ADHD), according to a study
Some expectant mothers who smoke during pregnancy may be exposing their baby to the risk of the attention deficit/hyperactivity disorder (ADHD), according to a study
ADHD Genes Found, Known To Play Roles In Neurodevelopment
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD.
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD.
FDA Certifies Novel ADHD Drug
Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.
Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.
